downregulating human leukocyte antigen (HLA) classical class I molecules 5 and upregulating nonclassical HLA-G molecules through secretion of cytokines, as interleukin-10 (IL-10). 6 HLA-G protein can be considered as a good candidate to be involved, at least partially, in the susceptibility to HCV infection and chronicity, both multifactorial conditions. HLA-G inhibits the cytolytic function of natural killer (NK) cells 7 and cytotoxic T lymphocytes (CTLs) 8 by directly binding the killer cell immunoglobulin-like receptor (KIRD2DL4) and specific leukocyte receptors such as leukocyte immunoglobulin like receptor B1 and B2 (LILRB1 and LILRB2). [9] [10] [11] Moreover it is also able to restrain the alloproliferative response of CD4 positive (CD4 + ) T cells 12 and the proliferation of NK and T cells, 13 shifting the immune response from T helper 1 (Th1) to Th2. 14 Weng et al 15 observed a raise of plasma soluble HLA-G (sHLA-G) in Chinese patients with chronic HCV infection, furthermore de Oliveira et al 16 observed the upregulation of soluble and membrane-bound HLA-G expression in Brazilian patients with the milder form of chronic hepatitis; additionally, when the functional effect of genetic variants in HLA-G gene was considered, Cordero et al 17 observed that the 3142G>C SNP play a role in the susceptibility to HCV infection; besides, da Silva et al 18 found an increased frequency of 14 bp insertion and 3142 G haplotype, associated with a low HLA-G expression, in African HIV (human immunodeficiency virus) and HCV coinfected patients. Therefore, considering the potential role of HLA-G in modulating susceptibility to viral infections as well as to HCV persistence and chronicity, taking into account that HLA-G mRNA expression is under genetic control and that the alleles frequencies vary among populations of different ethnic origin, 19 we designed an association study analyzing the ; polymorphisms at the promoter region have been also reported to affect HLA-G mRNA expression [21] [22] [23] [24] ; at the 850 base pairs from ATG to exon 3, where peptide signal and α1, α2 domains are encoded, specific genetic variations (such as null allele, G*0105N and G*0103N) cause lack of production of some or all HLA-G isoforms, [25] [26] [27] finally, 3 0 UTR contains regulatory elements, 28 as polyadenylation signals and AU-rich elements, 29 as well as signals regulating the spatial and temporal expression of HLA-G mRNA. 28 Sequencing analysis of the above-mentioned HLA-G regions has been performed in Italian HCV-positive patients and uninfected controls aimed at disclosing the involvement of functional genetic variations in the susceptibility to HCV infection.
| MATERIALS AND METHODS

| Patients and controls
We enrolled 258 HCV-positive patients from North-East Italy (Italian European Caucasian, 110 females, 148 males, mean age 65 AE 14.7 years), attended at the unit "Clinica Medica", Cattinara Hospital and "Italian Liver Foundation" Trieste (Italy). All the patients enrolled presented a chronic disease assessed by physicians through laboratory tests (Table 1) .
For HCV patients the inclusion criteria were: diagnosis of chronic hepatitis, histologically demonstrated (liver biopsy); positivity for HCV-RNA found in the qualitative test performed by polymerase chain reaction (PCR); elevated alanine transaminases (ALT), at least 1.5 times the norm for 6 months and age greater of 18 years. Exclusion criteria were as follows: no hepatic lesions, hepatocellular carcinoma, HIV coinfection, hepatitis B surface antigen positivity, alcohol or drug abuse, no history of tattoos, no autoimmune disorder (serum autoantibody evaluation), psychiatric disease with pharmacological treatment, anemia, alpha-1-antitripsina deficit and Wilson disease. 30 The control group consisted of 284 uninfected blood donors from North-East Italy (Italian European Caucasian, 93 females, 191 males, mean age 42.32 AE 9.82 years) ( Table 1 ). The exclusion criteria adopted were: presence of fever, cold or flu, pregnancy, puerperium, surgical procedures, vaccination or tattoos in the last 6 months and use of illicit drugs. Positivity to hepatitis, HIV, HTLV (human Tlymphotropic virus) and other infections were also exclusion factors.
The physician attending patients and controls assessed the ethnicity based on their place of birth and their genealogy (all individuals self reported at least 3 generations born in Italy), as well as skin color and somatic traits.
Written informed consent was obtained from all individuals. The IRCCS Burlo Garofolo Ethical Committee approved the research project CIB protocol L.-1055N. 118/10.
| DNA extraction and HLA-G genotyping
Genomic DNAs were extracted from peripheral whole blood of all patients and controls using salting out procedure (modified from Miller et al). HLA-G genotyping was performed by bi-directional sequencing of PCR amplicons (for primers and PCR conditions see 
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| HLA-G serum concentration
To assess the correlation between HLA-G polymorphisms and serum concentration of the protein an enzyme-linked immunosorbent assay (ELISA) test was performed using the HLA-G ELISA kit (n. MBS267094, EMELCA Bioscience, Breda, the Netherlands) following manufacturer's instruction.
| Statistical analysis
Allele and genotype frequencies were calculated by direct gene counting. Statistical significance of differences in allele and genotype frequencies was calculated using Fisher's exact test. The odds ratio (OR) and 95% confidence interval (CI) were also computed. For the polymorphisms associated with HCV infection susceptibility, the results were also adjusted for covariates age and sex using SNPassoc package for R.
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Haplotypes and linkage disequilibrium (LD) between HLA-G polymorphisms were evaluated with Arlequin 3.11 software (http://cmpg.unibe.ch/software/arlequin3). 33 Statistical significance of differences in haplotype frequencies was calculated with Fisher's exact test, (2 × 2 contingency tables, degrees of freedom = 1). The differences in HLA-G serum concentration between patients and controls were analyzed using Mann-Withney test, while correlations between HLA-G polymorphisms and serum HLA-G concentration were assessed using KruskallWallis test.
The open-source R package (www.r-project.org) was used for all statistical analyses. 34 
| RESULTS
HLA-G sequence analysis in 258 HCV patients and 284 uninfected controls evidenced the presence of 17 different polymorphisms at 5 0 URR, 25 in coding region and 8 at 3 0 UTR (Table S1 , Supporting information).
Some SNPs were not in Hardy-Weinberg equilibrium (HWE) in HCV patients (HWE results, with P values and χ 2 values, are presented in Table S1 ).
We compared HLA-G SNPs frequencies between HCV patients and uninfected controls: the statistically significant differences at 5 0 URR concerned alleles with a frequency minor than 5%, indeed, the −725 C>G>T T allele was significantly more frequent in HCV patients than controls (5.5% vs 2%, P = .01, OR 2.35, 95% CI 1.16-5.03); moreover the T allele correlated with HCV infection according to a dominant genetic model (when genotypes with at least 1 T allele were compared with genotypes that do not contain that allele) (P = .027, OR 2.23, 95% CI 1.07-4.87) even when adjusted for age and sex covariates (P = .007, OR 3.19, 95% CI 1.35-7.52) ( Table 3) . Also, the minor allele of the −509 C>G, −400 G>A and −398 G>A SNPs were significantly more frequent in HCV patients respect to controls: 3.5% vs 1% for −509 C>G SNP (P = .0018, OR 5.09, 95% CI 1.66-20.81) and 6% vs 3% for −400 G>A and −398 G>A SNPs (P = .009, OR 2.27, 95% CI 1.17-4.60); the statistically significance remained also after adjustment for age and sex (−509 C>G: P = .005, OR 5.44, 95% CI 1.56-18.99; −400 G>A and −398 G>A: P = .01, OR 2.89, 95% CI 1.25-6.69). These minor alleles were associated with a predisposing effect for infection, compatible with dominant genetic model: OR 4.62 for −509 C>G SNP (P = .0049, 95% CI 1. 46-19.22) and OR 2.09 for −400 G>A and −398 G>A SNPs (P = .03, 95% CI 1.04-4.34) ( Table 3) .
In HLA-G coding region, 7 SNPs (+15 G>A, +36 G>A, +372 G>A, insC506, +531 G>C, delA615 and +685 G>A), which start from exon 1 to intron 2, were in strong LD and constituted a haploblock (D 0 >0.99). The homozygous wild-type genotype of these SNPs was more frequent in HCV patients than controls (36% vs 25%), and these genotypes associated with HCV infection according to a recessive genetic model (P = .003, OR 1.83, 95% CI Abbreviations: F, forward; R, reverse; URR, upstream regulator region; UTR, untranslated region.
1.20-2.80); however, the statistical significance was lost after adjustment for age and sex (P = .71, OR 1.10, 95% CI 0.65-1.87). Also, the +644 G>T T/T and G/T genotypes were more frequent in HCV patients than in the controls (P = .003, OR 3.13, 95% CI 1.37-7.80), but not after correction for covariates age and sex (P = .09, OR 2.13, 95% CI 0.89-5.09).
Then, LD analysis was performed considering only the SNPs known from the literature to alter HLA-G expression and those located near HLA-G regulatory sites (−725C>G>T; −716 T>G; −201G>A; −56C>T; +292A>T; +755 C>A; delC814; 14 bp del/ins; 3142C>G; 3187A>G and 3196C>G).
The rare TTGTTCCIGAC (Table 4) haplotype was significantly more frequent in HCV patients with respect to uninfected controls (5% vs 1.5%, P = .004, OR 3.03, 95% CI 1.34-7.47) (data obtained by comparing the haplotype above with the sum of all other).
In addition, the serum concentrations of HLA-G were measured in 13 patients and 12 healthy controls. The median concentration was 51.72 U/mL (standard deviation = 34.46, range = 10.17-128.16) in the patients and 10.70 U/mL (standard deviation = 37.05, range = 0.00-125.55) in the controls. The HLA-G serum concentration was significantly different between patients and controls (P = .01).
Considering HLA-G polymorphisms, associated in this study with HCV infection, −725 C>G>T −509 C>G, −400 G>A,-398 G>A and +644 G>T polymorphisms were monomorphic in the samples analyzed and so comparison was not possible. Instead for the haploblock (+15 G>A, +36 G>A, +372 G>A, insC506, +531 G>C, delA615 and +685 G>A), no difference was present comparing the 3 genotypes within the groups of patients and controls.
| DISCUSSION
HCV causes acute but also chronic liver disease, the latter occurring in 60%-85% of cases as the virus is able to escape ; however, several studies observed a neo-expression of HLA-G linked to several pathological conditions, including HCV infection. 6, 39, 40 These upregulation mechanisms are still unclear, but it is thought that increased HLA-G expression is because of cytokines secretion, as Th2 IL-10 cytokine, 41 and that HLA-G molecule increases the expression of these cytokines.
14 HLA-G expression also depends upon HLA-G polymorphisms located in regulatory area of the gene, as 5 0 URR, which regulates gene expression 21 ; coding region, in which specific variations cause the formation of null allele, consequently not producing some or all HLA-G isoforms [25] [26] [27] ; 3 0 UTR that contains regulatory sites for mRNA stability. 28, 29 For this reason, in our study population these 3 HLA-G gene regions were sequenced and 50 SNPs were observed. Comparing the allelic and genotypic frequencies between HCV patients and uninfected controls 4 SNPs at HLA-G 5 0 URR, namely −725C>G>T, −509C>G, −400G>A and -398G>A, were more frequent in HCV patients with respect to the controls, also when the results obtained were adjusted for age and sex. The SNPs at position −509, −400 and −398 have a minor allele frequency (MAF) <5% and their functions are still unknown. However, Because these polymorphisms are located in proximity of regulatory sites, we hypothesize their possible involvement in affecting gene expression by impairment of regulatory factors binding. When looking at −725C>G>T SNP, the −725 T allele was more frequent in HCV patients than in uninfected controls; however, its function are still unknown. The −725G allele was reported to increase HLA-G transcription, 42, 43 although, a previous study, conducted by Moreau et al, showed that the presence of the G allele should create a CpG dinucleotide that can inhibit the binding of interferon regulatory factor-1 (IRF-1) to ISRE motif through increased methylation, thus lowering HLA-G transcription. 21 Moreover, exonic +15G>A, +36G>A and 372G>A SNPs and intronic insC506, +531G>C, delA615 and +685G>A SNPs (forming haploblock) as well as intronic +644G>T SNP were associated with HCV infection, but after correction for covariates age and sex the statistically significance was lost. In spite of the associations found, no functional role for these variants has been ever reported. Finally, we did not find different allelic and genotypic frequency distributions for the SNPs at the 3 0 UTR. Considering the serum concentration of the protein no differences were seen among the different genotypes of the SNPs here associated with HCV infection (because the samples analyzed are monomorphic), instead comparing patients and controls, the HCV-infected individuals presented a higher serum HLA-G concentration than controls; however, these results have to be considered cautiously as the low number of samples analyzed and the great standard deviation of the measurements. HLA-G expression levels are not only influenced by a single SNP but also by the combination of SNPs forming haplotypes. 19, 43 Indeed, we considered the -725C>G>T SNP, associated with altered HLA-G expression 25 ; −716 T>G SNP located close to a IRF-1 binding motif; −201G>A located in the nuclear factor-ķB2 element (enhancer A) 20 ; −56C>T SNPs located near to Ras responsive element binding protein 1 -(RREB1) motif and TATA box 20 ; +292A>T SNP, in which the mutation leads to aminoacid change (Thr55Ser); +755C>A SNP, that is a nonsynonymous SNP with amino acid change, Leu134Ile 42 ; delC814, in which the deletion characterizes the G*01:05N allele 25, 26 ; 14 bp del/ins SNP associated with mRNA instability 22 ; 3142C>G that is a preferential binding site of various miRNAs, increasing HLA-G mRNA instability 23 ; 3187A>G and 3196C>G SNPs located near an AU-rich motif that is implicated in mRNA degradation. 24 The haplotypes analysis indicated that in HCV patients, TTGTTCCIGAC haplotype (composed by −725C>G>T, −716 T>G, −201G>A, −56C>T, +292A>T, +755C>A, delC814, 14 bp del/ins, 3142C>G, 3187A>G, 3196C>G polymorphisms) was more frequent in HCV patients with respect to uninfected controls. This haplotype belongs to the HLA-G*01:03 allele (UTR5), 44 already associated to a significantly higher sHLA-G expression, 44, 45 possibly supporting our findings. Previous literature data agree, affirming that HLA-G upregulation happens during viral infections, 15,16 moreover higher HLA-G concentration could contribute to the establishment of HCV chronicity inhibiting the proliferation and function of NK cells and CTLs 7, 8, 13 and contributing to production of Th2 cytokines. 41 Nevertheless, it is important to consider that the healthy uninfected controls enrolled in this study are blood donors, without information available regarding their possible previous exposure to HCV. The most appropriate controls to analyze the impact of HLA-G polymorphisms on the susceptibility toward HCV infection should be composed by HCV exposed but uninfected subjects, unfortunately not available in this study, so the associations here reported should be considered cautiously.
Finally, we are aware that, although the most of the Pvalues reported presented a statistical significance below .01, applying Bonferroni's correction, the statistical significance will be lost in all cases. Because the effects of a gene in a multifactorial chronic diseases such as hepatitis C, is supposed to be small, the differences in polymorphisms' frequencies reported could be indicative of the involvement of HLA-G gene in HCV infection susceptibility. Nevertheless, we are interested in highlighting all the possible associations between HLA-G polymorphisms and HCV susceptibility, so setting a stringent Pvalue threshold, could possibly impede the identification of single small effects, considering that in multifactorial traits genes are characterized by low penetrance e variable expression.
The deviations from HWE of some SNPs have also to be taken into account. In particular, the different frequencies distributions of SNPs not in HWE between patients and controls could be due to a selection bias at the moment of the enrollment of the HCV infected population (stringent exclusion criteria have been adopted thus limiting the number of available subjects), or to the low minimum allele frequency (MAF) of the allele; a dominant effect of the allele linked to increased risk of infection susceptibility that introduced a divergence in the HWE could also be considered accounting for HWE deviation. Nevertheless all the frequencies of the SNPs analyzed were similar to those reported by 1000 Genomes project regarding the Toscani Italian population. TTGTTCCIGAC HLA-G*0103 allele, associate with higher sHLA-G expression 45, 46 Abbreviations: HLA-G, human leukocyte antigen-G; HCV, hepatitis C virus; URR, upstream regulator region.
In conclusion, being aware of the relative low number of subjects analyze in this study, and the fact that the associations found regarded SNPs with very low MAF, we found several HLA-G genetic variations and 1 haplotype associated were more frequent in HCV patients that in the uninfected controls (summarized in Table 5 ), but most of these variations are rare and its functional effects on the HLA-G gene expression is yet not known. Our functional analysis, conducted on a small number of individuals with available serum for analysis, did not contribute to clarify this issue, so our findings are not corroborated by sHLA-G serum evaluation. The next steps will be the genotypephenotype correlation, analyzing the relationships between HLA-G regulatory polymorphisms and HLA-G level in HCV patients, compared with uninfected individuals in a larger cohort of individuals, and an association study of the role of KIR2DL4 gene polymorphisms (the natural-killer receptor to which HLA-G is capable to bind 11 ) in HCV infection susceptibility analyzing also the possible correlation between KIR2DL4 and HLA-G polymorphisms.
